Please assess the completion status of the following clinical trial:

Trial Title: A Double Blind Clinical Trial of DCS for Food Anxiety

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with Anorexia Nervosa, Bulimia Nervosa, Eating Disorder Not Otherwise Specified~Exclusion Criteria:~* Pregnant or planning on becoming pregnant~* Psychotic or Manic

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Setraline (Type: EXPERIMENTAL): 250 mg DCS (setraline) versus placebo plus exposure
- placebo (Type: PLACEBO_COMPARATOR): Placebo group plus exposure

Based on this trial design, predict the completion outcome and termination type (if applicable).